These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase. Bertorini TE; Shively V; Taylor B; Palmieri GM; Fox IH Neurology; 1985 Sep; 35(9):1355-7. PubMed ID: 3860749 [TBL] [Abstract][Full Text] [Related]
23. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model. Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271 [TBL] [Abstract][Full Text] [Related]
24. In McArdle disease, phosphorylase deficiency is the tip of an iceberg. Willner JH; Cerri CG; Wood DS; Ponzetto-Zimmerman C; Reydel PM Trans Am Neurol Assoc; 1981; 106():208-9. PubMed ID: 6294950 [No Abstract] [Full Text] [Related]
29. Increased ammonia production during forearm ischemic work test in McArdle's disease. Rumpf KW; Wagner H; Kaiser H; Meinck HM; Goebel HH; Scheler F Klin Wochenschr; 1981 Dec; 59(23):1319-20. PubMed ID: 6947119 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart. Miranda AF; Nette EG; Hartlage PL; DiMauro S Neurology; 1979 Nov; 29(11):1538-41. PubMed ID: 291791 [TBL] [Abstract][Full Text] [Related]
31. McArdle's disease with non-insulin-dependent diabetes mellitus: the beneficial effects of hyperglycemia and hyperinsulinemia for exercise intolerance. Yamauchi A; Amano K; Ichikawa Y; Nakamoto S; Takei I; Maruyama H; Kono N; Saruta T Intern Med; 1996 May; 35(5):403-6. PubMed ID: 8797056 [TBL] [Abstract][Full Text] [Related]
32. Adult-onset exercise intolerance due to phosphorylase b kinase deficiency. Bak H; Cordato D; Carey WF; Milder D J Clin Neurosci; 2001 May; 8(3):286-7. PubMed ID: 11386811 [TBL] [Abstract][Full Text] [Related]
33. McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance. Bogusky RT; Taylor RG; Anderson LJ; Angelos KL; Lieberman JS; Walsh DA J Clin Invest; 1986 Jun; 77(6):1881-7. PubMed ID: 3458722 [TBL] [Abstract][Full Text] [Related]
34. [Glucose metabolism during muscular exercise in McArdle's disease]. Krzentowski G; Pallikarakis N; Pirnay F Acta Clin Belg; 1979; 34(3):151-7. PubMed ID: 292291 [No Abstract] [Full Text] [Related]
35. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease. Wagenmakers AJ; Coakley JH; Edwards RH Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889 [TBL] [Abstract][Full Text] [Related]
36. Congenital myopathy due to phosphorylase deficiency. Cornelio F; Bresolin N; DiMauro S; Mora M; Balestrini MR Neurology; 1983 Oct; 33(10):1383-5. PubMed ID: 6577313 [TBL] [Abstract][Full Text] [Related]
37. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease. Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661 [TBL] [Abstract][Full Text] [Related]
38. [Hepatic glycogenoses. Correlations between the clinical and biochemical characteristics and the type of enzymatic deficiency: glucose-6-phosphatase, amylo-1-6-glucosidase, phosphorylase]. GABILAN JC Rev Int Hepatol; 1960; 10():699-818. PubMed ID: 13702771 [No Abstract] [Full Text] [Related]
39. No spontaneous second wind in muscle phosphofructokinase deficiency. Haller RG; Vissing J Neurology; 2004 Jan; 62(1):82-6. PubMed ID: 14718702 [TBL] [Abstract][Full Text] [Related]
40. The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa. Pieniazek D; Pronicka E; Pawłowska J Horm Metab Res; 1986 Aug; 18(8):546-50. PubMed ID: 3093350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]